European Drug Laws For Prescription Drug
Prescription drug abuse can affect any country through a range of substances. The most prevalent issues tend to involve opioids (painkillers), depressants (sleeping pills and anxiety medication) and stimulants (ADHD medication).
It is important for healthcare providers across Europe to be able to tackle the problem of drug dependency in a positive manner. This means creating strong EU drug laws that help the addict.
It is important for European nations to tackle the issue of abusing prescription drugs before it gets out of control. It is also important to provide a safe way of dealing with synthetic opioids for substitution medication.
Both issues have to lead to some different policies across the continent. Some are understandable and beneficial while others have been a little more controversial.
There Are Major Concerns In Europe About The Regulation Of Prescription Drugs Such As Opioids, Stimulants, And Depressant
The EU needs to maintain strong drug laws and health care policies to provide the best support for drug addicts. The rise in the use of stimulants, such as Adderall and Ritalin, is a big concern in some European countries.
The prescription is increasing in Iceland, Norway, Sweden, Belgium and Germany. Germany seems to be dealing with prescription drug abuse fairly well. However, over countries may soon see a rise in stimulant abuse and a need for tighter drug laws.
Depressant abuse is another area where cases to rise quickly. More and more of us are taking these pills for sleeping disorders, anxiety, and other related conditions. The fear is that dependency will lead to prescription depressant abuse and further health problems.
The UNODC do not currently see depressant abuse as a pressing issue in Europe. This leads to fears that the matter is slipping between the cracks a little. There is a trend for users to combine depressants with other medications and alcohol, which could cause further damage.
The Biggest Issue Right Now Is The Control Of Prescribed Opioids.
Heroin deaths in Europe are on the decline, which suggests there are beneficial programs and drug regulations. However, deaths from synthetic opioids are increasing. Estonia alone saw a 38% increase between 2011 and 2012.
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) now wants to see improved surveillance measures for users of synthetic opioid treatments. It’s hoped that better control will manage this problem before Europe sees the same impact as America. Improved regulation can also help to stop these substances from entering the illegal market for re-sale.
There are two factors here that the EU needs to deal with when creating new drug laws. The first is the problem of painkiller users becoming dependent on these drugs for relief. This leads to issues of over-medication, fraudulent prescriptions, and even theft.
The other factor is the use of prescribed opioids and similar substances as substitution medication for addicts. Both areas need strong policies and regulation to tackle the problems of dependency and abuse.
Drug Laws Controlling Prescribed Opioids And Substitution Medication Are Crucial.
Policies on the controlled use and administration of synthetic opioids and replacement medication are essential when fighting abuse of prescription drugs. Change medications are an important tool in helping drug addicts to recover.
Synthetic substances are a big help for opiate addicts looking to quit illicit substances like heroin. At their best, these elements offer a similar response in a controlled environment.
The problem is that users can become equally dependent on these synthetic options and control is not always easy to maintain.
As of 2012, methadone remained the most commonly prescribed substitute for opiate addicts, with up to 75% of users taking it. This could be partial because methadone is also one of the cheapest options for healthcare providers.
The other 25% depended on the country of origin. Different nations have different approaches to the best treatment options. Diacetylmorphine is used in a minority of EU countries (Belgium, Denmark, Germany, Spain, Netherlands, and the United Kingdom) while it is not permitted elsewhere. Other countries offer slow-release morphine, codeine or buprenorphine-naloxone depending on individual drug policies.
There needs to be a balance between the controlled prescription of this substance and availability. Addicts cannot only obtain these drugs whenever they want and essentially substitute their addiction.
However, health care providers need to provide a viable alternative to illegal, unregulated drug. There are always going to be disputes over the best drugs to use and the best ways of providing them to patients.
Drug Laws On Prescription Drugs For Substitution Medication Can Be Quite Controversial And Varied.
There are many different approaches to health care and drug availability in the EU. EU policies offer guidelines on a range of issues, but each country can have their interpretation. For example, it is legal for all countries in the EU to sell syringes without a prescription, except Sweden.
At the same time, this policy causes some mixed feeling, and some pharmacies choose not to do so. There is the fear that open sales of syringes will encourage unlimited drug use.
Synthetic opiate use can work when it is controlled and used as a treatment option alongside other resources. The problem comes in finding the best way to provide these substances and prevent abuse. One of the most controversial policies occurred in central Europe in 2004. Dutch, German and Swiss authorities set up “safe consumption rooms” for users.
These rooms were spaces where addicts could take these substances in a safe, hygienic environment. The idea is still controversial today, but there were clear benefits. Users could receive the drugs they needed in a controlled way while also accessing support, counseling, and other resources.
These Various Regulations Mean Different Results And Views In The Different Countries.
Prescription drugs for pain and opiate addiction are essential. However, there is a fine line between creating an open door and shutting addicts out.
EU drug laws provide a basis on which drugs to use and how best to treat addicts. It is then up to individual countries to find the best method for their nation’s problem.